{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T22:36:48Z","timestamp":1770676608379,"version":"3.49.0"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T00:00:00Z","timestamp":1768608000000},"content-version":"vor","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018955","name":"NIHR Leeds Biomedical Research Centre","doi-asserted-by":"publisher","award":["NIHR203331"],"award-info":[{"award-number":["NIHR203331"]}],"id":[{"id":"10.13039\/501100018955","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>PMR is a common inflammatory condition characterized by pain and stiffness in the shoulders and hips. Patient experiences of PMR remain underexplored and often diverge significantly from clinician perspectives, contributing to the overall burden of the disease. This review forms part of an ongoing project conducted by the PMR Working Group of Outcome Measures in Rheumatology (OMERACT) with the aim of exploring patient views of \u2018relapse\u2019 and \u2018remission\u2019.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A comprehensive search was conducted across four electronic databases (Ovid MEDLINE, Ovid EMBASE, The Cochrane Library and CINAHL) from database inception to 31\/01\/2025, to identify qualitative studies reporting patient experience in PMR. Study quality was appraised using the Critical Appraisal Skills Programme qualitative tool, and thematic synthesis used to integrate findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Five studies met inclusion criteria and thematic analysis revealed three overarching themes: (1) the pathway to diagnosis, (2) managing uncertainty and (3) challenges to everyday life. Subthemes provided deeper insights into patient experiences, including delays in help-seeking due to the rationalization of symptoms, and complex responses to glucocorticoid treatment, described by participants as a \u2018double-edged sword\u2019, offering rapid improvement in symptoms but also causing significant distress. Notably, commonly used clinical terms such as \u2018relapse\u2019 and \u2018remission\u2019 were often inconsistent with how patients described their own experiences, underscoring a gap between clinical definitions and patient experiences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This qualitative narrative literature review reveals the unique challenges of disease management and the complex realities of long-term glucocorticoid use. These findings highlight the urgent need for more patient-centred approaches to care and support.<\/jats:p>\n                    <jats:p>Key messages Patients often delay seeking care by normalizing symptoms. Glucocorticoids rapidly relieve PMR symptoms but cause distressing side effects and emotional uncertainty for patients. Clinical terms like relapse and remission often misalign with patient experiences, requiring more patient-centred language.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rap\/rkag006","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T12:34:34Z","timestamp":1768566874000},"source":"Crossref","is-referenced-by-count":0,"title":["Patient experiences of PMR: a qualitative narrative literature review"],"prefix":"10.1093","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3977-8920","authenticated-orcid":false,"given":"Max","family":"Yates","sequence":"first","affiliation":[{"name":"Norwich Medical School, University of East Anglia , Norwich,","place":["UK"]},{"name":"Department of Rheumatology, Norfolk and Norwich University Hospital , Norwich,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2762-3015","authenticated-orcid":false,"given":"Janice","family":"Mooney","sequence":"additional","affiliation":[{"name":"School of Health and Social Care, University of Staffordshire , Stafford,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4212-5875","authenticated-orcid":false,"given":"Pratyasha","family":"Saha","sequence":"additional","affiliation":[{"name":"Norwich Medical School, University of East Anglia , Norwich,","place":["UK"]},{"name":"Department of Rheumatology, Norfolk and Norwich University Hospital , Norwich,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2694-5411","authenticated-orcid":false,"given":"Claire E","family":"Owen","sequence":"additional","affiliation":[{"name":"Department of Medicine, The University of Melbourne , Parkville, Victoria,","place":["Australia"]},{"name":"Department of Rheumatology, Austin Health , Heidelberg, Victoria,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2483-5873","authenticated-orcid":false,"given":"Sarah L","family":"Mackie","sequence":"additional","affiliation":[{"name":"Leeds Institute for Rheumatic and Musculoskeletal Medicine, University of Leeds , Leeds,","place":["UK"]},{"name":"Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust , Leeds,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9449-6056","authenticated-orcid":false,"given":"Louise","family":"Falzon","sequence":"additional","affiliation":[{"name":"School of Medicine and Population Health, University of Sheffield , Sheffield,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3855-6763","authenticated-orcid":false,"given":"Aatke","family":"Van der Maas","sequence":"additional","affiliation":[{"name":"Rheumatology, Sint Maartenskliniek , Ubbergen,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3911-3515","authenticated-orcid":false,"given":"Thomas","family":"Bolhuis","sequence":"additional","affiliation":[{"name":"Rheumatology, Sint Maartenskliniek , Ubbergen,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6783-6422","authenticated-orcid":false,"given":"Philipp","family":"Bosch","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Medical University of Graz , Graz,","place":["Austria"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0173-0668","authenticated-orcid":false,"given":"Christian","family":"Dejaco","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Medical University of Graz , Graz,","place":["Austria"]},{"name":"Department of Rheumatology, Hospital of Bruneck (ASAA-SABES) , Brunico,","place":["Italy"]},{"name":"Department of Rheumatology, Teaching Hospital of the Paracelsius Medical University , Brunico,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorna","family":"Neill","sequence":"additional","affiliation":[{"name":"Patient Charity Polymyalgia Rheumatica and Giant Cell Arteritis Scotland , Dundee,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"McGee","sequence":"additional","affiliation":[{"name":"School of Health Sciences, University of East Anglia , Norwich,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"key":"2026020901264161100_rkag006-B1","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1136\/annrheumdis-2018-213883","article-title":"Incidence, prevalence and treatment burden of polymyalgia rheumatica in the UK over two decades: a population-based study","volume":"77","author":"Partington","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2026020901264161100_rkag006-B2","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s12891-016-1127-3","article-title":"The prevalence of giant cell arteritis and polymyalgia rheumatica in a UK primary care population","volume":"17","author":"Yates","year":"2016","journal-title":"BMC Musculoskelet Disord"},{"key":"2026020901264161100_rkag006-B3","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1136\/ard.42.4.374","article-title":"Polymyalgia rheumatica and corticosteroids: how much for how long?","volume":"42","author":"Behn","year":"1983","journal-title":"Ann Rheum Dis"},{"key":"2026020901264161100_rkag006-B4","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0002-9343(85)90309-2","article-title":"Polymyalgia rheumatica. Duration of therapy and long-term outcome","volume":"79","author":"Ayoub","year":"1985","journal-title":"Am J Med"},{"key":"2026020901264161100_rkag006-B5","first-page":"494","article-title":"Difficulties and complications in the therapeutic use of ACTH and adrenocortical steroids in the rheumatic diseases. Discussion","volume":"10","author":"Hench","year":"1951","journal-title":"Ann Rheum Dis"},{"key":"2026020901264161100_rkag006-B6","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/bmj.2.5649.99","article-title":"Polymyalgia rheumatica","volume":"2","author":"Hart","year":"1969","journal-title":"Br Med J"},{"key":"2026020901264161100_rkag006-B7","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1136\/annrheumdis-2021-221126","article-title":"Tocilizumab in patients with new onset polymyalgia rheumatica (PMR-SPARE): a phase 2\/3 randomised controlled trial","volume":"81","author":"Bonelli","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"2026020901264161100_rkag006-B8","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1056\/NEJMoa2303452","article-title":"Sarilumab for relapse of polymyalgia rheumatica during glucocorticoid taper","volume":"389","author":"Spiera","year":"2023","journal-title":"N Engl J Med"},{"key":"2026020901264161100_rkag006-B9","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/rheumatology\/keaa209","article-title":"Glucocorticoid use is associated with an increased risk of hypertension","volume":"60","author":"Costello","year":"2021","journal-title":"Rheumatology"},{"key":"2026020901264161100_rkag006-B10","doi-asserted-by":"crossref","first-page":"e1002024","DOI":"10.1371\/journal.pmed.1002024","article-title":"Common infections in patients prescribed systemic glucocorticoids in primary care: a population-based cohort study","volume":"13","author":"Fardet","year":"2016","journal-title":"PLOS Med"},{"key":"2026020901264161100_rkag006-B11","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1007\/s00198-013-2352-3","article-title":"Influence of recency and duration of glucocorticoid use on bone mineral density and risk of fractures: population-based cohort study","volume":"24","author":"Majumdar","year":"2013","journal-title":"Osteoporos Int"},{"key":"2026020901264161100_rkag006-B12","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.rmed.2009.01.003","article-title":"The cumulative burden of oral corticosteroid side effects and the economic implications of steroid use","volume":"103","author":"Manson","year":"2009","journal-title":"Respir Med"},{"key":"2026020901264161100_rkag006-B13","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s001980200108","article-title":"The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis","volume":"13","author":"van Staa","year":"2002","journal-title":"Osteoporos Int"},{"key":"2026020901264161100_rkag006-B14","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.3899\/jrheum.161083","article-title":"A patient-reported outcome measure for effect of glucocorticoid therapy in adults with inflammatory diseases is needed: report from the OMERACT 2016 special interest group","volume":"44","author":"Black","year":"2017","journal-title":"J Rheumatol"},{"key":"2026020901264161100_rkag006-B15","doi-asserted-by":"crossref","first-page":"e783","DOI":"10.3399\/bjgp18X699557","article-title":"Challenges of diagnosing and managing polymyalgia rheumatica: a multi-methods study in UK general practice","volume":"68","author":"Helliwell","year":"2018","journal-title":"Br J Gen Pract"},{"key":"2026020901264161100_rkag006-B16","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1620\/tjem.251.125","article-title":"High relapse rate in patients with polymyalgia rheumatica despite the combination of immunosuppressants and prednisolone: a single center experience of 89 patients","volume":"251","author":"Okazaki","year":"2020","journal-title":"Tohoku J Exp Med"},{"key":"2026020901264161100_rkag006-B17","doi-asserted-by":"crossref","first-page":"e0126758","DOI":"10.1371\/journal.pone.0126758","article-title":"\"An impediment to living life\": why and how should we measure stiffness in polymyalgia rheumatica?","volume":"10","author":"Mackie","year":"2015","journal-title":"PLoS One"},{"key":"2026020901264161100_rkag006-B18","doi-asserted-by":"crossref","first-page":"A155","DOI":"10.1136\/annrheumdis-2013-eular.503","article-title":"How general practitioners diagnose polymyalgia rheumatica","volume":"72","author":"Helliwell","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2026020901264161100_rkag006-B19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2147\/OARRR.S213964","article-title":"A qualitative study of patient perspectives related to glucocorticoid therapy in polymyalgia rheumatica and giant cell arteritis","volume":"11","author":"Hoon","year":"2019","journal-title":"Open Access Rheumatol"},{"key":"2026020901264161100_rkag006-B20","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.pec.2014.12.013","article-title":"\"I suddenly felt I\u2019d aged\": a qualitative study of patient experiences of polymyalgia rheumatica (PMR)","volume":"98","author":"Twohig","year":"2015","journal-title":"Patient Educ Couns"},{"key":"2026020901264161100_rkag006-B21","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2026020901264161100_rkag006-B22","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1007\/s10067-023-06794-3","article-title":"Exploring the patient experience in polymyalgia rheumatica","volume":"42","author":"Harris","year":"2023","journal-title":"Clin Rheumatol"},{"key":"2026020901264161100_rkag006-B23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1191\/1478088706qp063oa","article-title":"Using thematic analysis in psychology","volume":"3","author":"Braun","year":"2006","journal-title":"Qual Res Psychol"},{"key":"2026020901264161100_rkag006-B24","doi-asserted-by":"crossref","first-page":"e014301","DOI":"10.1136\/bmjopen-2016-014301","article-title":"Patients\u2019 views on the causes of their polymyalgia rheumatica: a content analysis of data from the PMR cohort study","volume":"7","author":"Tshimologo","year":"2017","journal-title":"BMJ Open"},{"key":"2026020901264161100_rkag006-B25","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1093\/rheumatology\/ker017","article-title":"Prevalence of long-term oral glucocorticoid prescriptions in UK over the past 20 years","volume":"50","author":"Fardet","year":"2011","journal-title":"Rheumatology"},{"key":"2026020901264161100_rkag006-B26","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.3899\/jrheum.190575","article-title":"Feasibility and face validity of outcome measures for use in future studies of polymyalgia rheumatica: an OMERACT study","volume":"47","author":"Yates","year":"2020","journal-title":"J Rheumatol"},{"key":"2026020901264161100_rkag006-B27","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/ard-2022-223429","article-title":"Treat-to-target recommendations in giant cell arteritis and polymyalgia rheumatica","volume":"83","author":"Dejaco","year":"2024","journal-title":"Ann Rheum Dis"}],"container-title":["Rheumatology Advances in Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumap\/advance-article-pdf\/doi\/10.1093\/rap\/rkag006\/66436754\/rkag006.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumap\/article-pdf\/10\/1\/rkag006\/66436754\/rkag006.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumap\/article-pdf\/10\/1\/rkag006\/66436754\/rkag006.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T06:26:50Z","timestamp":1770618410000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumap\/article\/doi\/10.1093\/rap\/rkag006\/8428130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,2]]}},"URL":"https:\/\/doi.org\/10.1093\/rap\/rkag006","relation":{},"ISSN":["2514-1775"],"issn-type":[{"value":"2514-1775","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026]]},"published":{"date-parts":[[2026]]},"article-number":"rkag006"}}